Author

J. Iwasawa

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Evolutionary Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Organism:E. coli· 2 Assay:bulk RNA-seq· 1 Approach:machine learning (classical)· 1 Assay:proteomics· 1 Approach:statistical model· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

C. Furusawa· 2 shared H. Kotani· 2 shared M. Kawada· 2 shared T. Maeda· 2 shared A. Sakai· 1 shared A. Shibai· 1 shared K. Tanabe· 1 shared N. Sakata· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 32 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersEvolutionary Biology

C. Furusawa

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Evolutionary BiologybioRxivPreprintAug 23, 2022

Multi-dimensional antibiotic resistance time series reveals the phenotype-based fitness landscape for Escherichia coli

J. Iwasawa, T. Maeda, A. Shibai…·C. Furusawa

The paper infers a phenotype-based fitness landscape for antibiotic resistance in Escherichia coli using multi-dimensional time-series drug resistance data to predict evolutionary trajectories.

DOI 10.1101/2022.08.23.504962

E. coliproteomics

𝕏 PostBluesky

Evolutionary BiologybioRxivFeb 19, 2020

High-throughput laboratory evolution and evolutionary constraints in Escherichia coli

T. Maeda, J. Iwasawa, H. Kotani…·C. Furusawa

This study uses high-throughput lab evolution of E. coli to identify evolutionary constraints and trade-offs in antibiotic resistance.

DOI 10.1038/s41467-020-19713-w

E. coliwhole-genome sequencing

𝕏 PostBluesky